Effect of Family History on Outcomes in Patients Treated With Definitive Brachytherapy for Clinically Localized Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 24-29

  Peters, Christopher A ^a   Stock, Richard G ^a   Blacksburg, Seth R ^a   Stone, Nelson N ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Brachytherapy; Familial prostate cancer; Outcomes research; Prostate cancer; Radiotherapy

Indexed keywords

DECISION MAKING; DOSIMETRY; MULTIVARIANT ANALYSIS; PATIENT MONITORING; RADIOTHERAPY;

BIOCHEMICAL CONTROLS; BIOCHEMICAL OUTCOMES; BRACHYTHERAPY; COMBINATION THERAPIES; EFFECTIVE DOSES; EXTERNAL BEAM RADIATION THERAPIES; FAMILIAL PROSTATE CANCER; FREEDOM FROM BIOCHEMICAL FAILURES; GLEASON SCORES; LOCALIZED PROSTATE CANCERS; MULTIVARIATE ANALYSES; OUTCOMES RESEARCH; PROSTATE CANCER; PROSTATE CANCERS;

TURBULENT FLOW;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RISK; CANCER STAGING; FAMILY HISTORY; FOLLOW UP; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; FAMILY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; NEW YORK; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 57649100389     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.031     Document Type: Article

References (24)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Ghadirian P., Howe G.R., Hislop T.G., et al. Family history of prostate cancer: A multi-center case-control study in Canada. Int J Cancer 70 (1997) 679-681
3. Spitz M.R., Currier R.D., Fueger J.J., et al. Familial patterns of prostate cancer: A case-control analysis. J Urol 146 (1991) 1305-1307
4. Steinberg G.D., Carter B.S., Beaty T.H., et al. Family history and the risk of prostate cancer. Prostate 17 (1990) 337-347
5. Carter B.S., Bova G.S., Beaty T.H., et al. Hereditary prostate cancer: Epidemiologic and clinical features. J Urol 150 (1993) 797-802
6. Lesko S.M., Rosenberg L., and Shapiro S. Family history and prostate cancer risk. Am J Epidemiol 144 (1996) 1041-1047
7. Bauer J.J., Srivastava S., Connelly R.R., et al. Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy. Urology 51 (1998) 970-976
8. Hanus M.C., Zagars G.K., and Pollack A. Familial prostate cancer: Outcome following radiation therapy with or without adjuvant androgen ablation. Int J Radiat Oncol Biol Phys 43 (1999) 379-383
9. Kupelian P.A., Kupelian V.A., Witte J.S., et al. Family history of prostate cancer in patients with localized prostate cancer: An independent predictor of treatment outcome. J Clin Oncol 15 (1997) 1478-1480
10. Kupelian P.A., Reddy C.A., Reuther A.M., et al. Aggressiveness of familial prostate cancer. J Clin Oncol 24 (2006) 3445-3450
11. Ray M.E., Dunn R.L., Cooney K.A., et al. Family history of prostate cancer and relapse after definitive external beam radiation therapy. Int J Radiat Oncol Biol Phys 57 (2003) 371-376
12. Hanlon A.L., and Hanks G.E. Patterns of inheritance and outcome in patients treated with external beam radiation for prostate cancer. Urology 52 (1998) 735-738
13. Roehl K.A., Loeb S., Antenor J.A., et al. Characteristics of patients with familial vs. sporadic prostate cancer. J Urol 176 (2006) 2438-2442 discussion 2442
14. Wong Y.N., Mitra N., Hudes G., et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 296 (2006) 2683-2693
15. Fleming I., and Cooper J. AJCC 1992 staging system (1992), Lippincott-Raven, Philadelphia
16. Stock R.G., Stone N.N., Wesson M.F., et al. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 32 (1995) 219-225
17. Stone N.N., and Stock R.G. Prostate brachytherapy: Treatment strategies. J Urol 162 (1999) 421-426
18. Peters C.A., Stock R.G., Cesaretti J.A., et al. TGFB1 Single Nucleotide Polymorphisms are Associated with Adverse Quality of Life in Prostate Cancer Patients Treated with Radiotherapy. Int J Radiat Oncol Biol Phys (2007)
19. Stock R.G., Cahlon O., Cesaretti J.A., et al. Combined modality treatment in the management of high-risk prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 1352-1359
20. Stock R.G., Stone N.N., Cesaretti J.A., et al. Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys 64 (2006) 527-533
21. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
22. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
23. Kupelian P.A., Klein E.A., Witte J.S., et al. Familial prostate cancer: A different disease?. J Urol 158 (1997) 2197-2201
24. Gronberg H., Isaacs S.D., Smith J.R., et al. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA 278 (1997) 1251-1255